Azenta, Inc. (AZTA) Stock
2 members of Congress disclosed 9 trades in AZTA since 2021: 4 purchases and 5 sales, most recently Gilbert Cisneros (purchase, Mar 3, 2026). 5 of the hedge funds AlphaScala tracks reported AZTA in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is D.E. Shaw's at $34.23M. Company insiders reported 1 open-market buy and 0 sales on SEC Form 4 in the 90 days to Oct 21, 2026.
Which members of Congress traded Azenta, Inc. (AZTA)?
Most recent: Gilbert Cisneros (purchase, Mar 3, 2026); records start Dec 3, 2021.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Gil Cisneros D-CA · House | 2026-03-03 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2026-01-15 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2025-10-09 | purchase | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2025-03-19 | sale | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2023-09-15 | partial sale | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2023-07-14 | purchase | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2023-06-13 | partial sale | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2021-12-15 | partial sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 20, 2026.
See all AZTA political trades →Which hedge funds own AZTA?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| D.E. Shaw David Shaw | 1.34M | $34.23M | +97% |
| Citadel Ken Griffin | 596K | $15.21M | +9% |
| Millennium Management Israel Englander | 163K | $4.17M | +150% |
| Marshall Wace | 121K | $3.08M | NEW |
| Point72 Steve Cohen | 67K | $1.70M | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Azenta, Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Jul 31, 26 | Starr Ephraim | SVP, Gen Counsel & Secretary | BUY | 335 | $8K |
SEC Form 4 filings as of Oct 21, 2026
See cluster-buy signals across all tickers →AZTA price chart
Powered by TradingViewWhat does Azenta, Inc. do?
Azenta, Inc. is a provider of life sciences solutions specializing in cold-chain sample management and multiomics services for pharmaceutical, biotechnology, academic, and healthcare institutions worldwide. The company operates through two primary segments: Sample Management Solutions, which offers automated storage systems, cryogenic equipment, sample tubes, consumables, instruments, controlled-rate thawing devices, and biorepository services to ensure the secure handling and long-term preservation of biological and chemical samples; and Multiomics, which delivers genomic analysis including next-generation sequencing and gene synthesis through its GENEWIZ brand. Azenta supports drug development, clinical research, and advanced cell therapies by maintaining sample integrity via its global biorepository network and providing essential infrastructure for precision medicine initiatives. Notable brands under Azenta include FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey, covering sample management tools, informatics, and cold-chain technologies. With operations across North America, Europe, and Asia, and headquartered in Burlington, Massachusetts, Azenta plays a critical role in the life sciences ecosystem by enabling efficient workflows for high-impact research and development programs.